Search - tctmd.com

Displaying 1 - 20 of 143

Sort: Relevancy | Date

News Conference News TCT 2019

IVUS-XPL at 5 Years Shows Durability of Imaging Guidance in PCI

Caitlin E. Cox

October 08, 2019

News Conference News TCT 2019

Intravascular Lithotripsy Shows Good Safety at 30 Days: DISRUPT CAD II

Yael L. Maxwell

October 08, 2019

News Conference News TCT 2019

Tailored Hydration Strategy Cuts Contrast-Induced Kidney Injury: REMEDIAL III

Michael O'Riordan

October 03, 2019

News Daily News TCT 2019

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

L.A. McKeown

October 02, 2019

News Conference News TCT 2019

Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE

Michael O'Riordan

September 30, 2019

Presentation TCT 2019

BIODEGRADE: A Large-Scale Randomized Trial of a Thin-Strut Bioabsorbable Polymer-Based DES vs. a Thick-Strut Bioabsorbable Polymer-Based DES in an All-Comers Population With Coronary Artery Disease

Presenter: IN-HO CHAE

September 29, 2019

Presentation TCT 2019

Development of the Coronary Stent: The Pioneers and Their Stories

Presenter: Philippe Gaspard

September 29, 2019

News Conference News TCT 2019

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Michael O'Riordan

September 29, 2019

Presentation TCT 2019

Stent Choice in Complex Lesions: How the Unique Stent DNA Can Help Improve the Patient Outcomes

Presenter: Prathap Kumar

September 28, 2019

Presentation TCT 2019

Bioresorbable Scaffolds: Global Development Pipeline

Presenter: Yoshinobu Onuma

September 28, 2019

Presentation TCT 2019

BRS Use in Primary PCI: Rational and Emerging Clinical Data

Presenter: Manel Sabate

September 28, 2019

News Conference News TCT 2019

EXCEL at 5 Years: PCI for Left Main CAD Still Noninferior to CABG

Marcus A. Banks

September 28, 2019

Presentation TCT 2019

The Post-Absorb BVS Era: Lessons Learned and Implications for Trial Design and Device Approval

Presenter: Andrew Farb

September 28, 2019

Presentation TCT 2019

Late Benefits From BVS: Theory and Evidence

Presenter: Gregg Stone

September 28, 2019

Presentation TCT 2019

How OCT Can Help Better Predict MACE Events in Left Main vs. IVUS: ROCK-II Retrospective Update

Presenter: Mani Selvamani

September 28, 2019

Presentation TCT 2019

The Absorb BVS Epilogue: How Did We Miss the Safety Signals?

Presenter: Renu Virmani

September 28, 2019

Presentation TCT 2019

Sirolimus-Coated Balloon Therapy: State of Development

Presenter: Stefan Verheye

September 28, 2019

Presentation TCT 2019

DAPT After PCI With DCB: Current Guidelines and Special Considerations

Presenter: Marco Valgimigli

September 28, 2019

Presentation TCT 2019

Emerging Data on Drug-Coated Balloon Use in the High Bleeding or High Thrombotic Risk Patient

Presenter: Bruno Scheller

September 28, 2019

Presentation TCT 2019

Drug-Coated Balloons in De Novo Lesions: Case Vignettes From Asia

Presenter: Paul Ong

September 28, 2019

Advertisement

IVUS-XPL at 5 Years Shows Durability of Imaging Guidance in PCI

Intravascular Lithotripsy Shows Good Safety at 30 Days: DISRUPT CAD II

Tailored Hydration Strategy Cuts Contrast-Induced Kidney Injury: REMEDIAL III

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE

BIODEGRADE: A Large-Scale Randomized Trial of a Thin-Strut Bioabsorbable Polymer-Based DES vs. a Thick-Strut Bioabsorbable Polymer-Based DES in an All-Comers Population With Coronary Artery Disease

Development of the Coronary Stent: The Pioneers and Their Stories

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Stent Choice in Complex Lesions: How the Unique Stent DNA Can Help Improve the Patient Outcomes

Bioresorbable Scaffolds: Global Development Pipeline

BRS Use in Primary PCI: Rational and Emerging Clinical Data

EXCEL at 5 Years: PCI for Left Main CAD Still Noninferior to CABG

The Post-Absorb BVS Era: Lessons Learned and Implications for Trial Design and Device Approval

Late Benefits From BVS: Theory and Evidence

How OCT Can Help Better Predict MACE Events in Left Main vs. IVUS: ROCK-II Retrospective Update

The Absorb BVS Epilogue: How Did We Miss the Safety Signals?

Sirolimus-Coated Balloon Therapy: State of Development

DAPT After PCI With DCB: Current Guidelines and Special Considerations

Emerging Data on Drug-Coated Balloon Use in the High Bleeding or High Thrombotic Risk Patient

Drug-Coated Balloons in De Novo Lesions: Case Vignettes From Asia

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content